"10.1371_journal.pone.0076558","plos one","2013-09-27T00:00:00Z","Eric A Gehrie; Hui Nian; Pampee P Young","Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America; Tennessee Valley Veterans Affairs Hospital, Nashville, Tennessee, United States of America","Conceived and designed the experiments: EG PYY. Performed the experiments: EG. Analyzed the data: EG PYY HN. Contributed reagents/materials/analysis tools: EG PYY HN. Wrote the manuscript: EG PYY HN.","The authors have read the journal's policy and have the following conflicts: 1) The study was funded in part by a grant from Alexion Pharmaceuticals, the manufacturer of eculizumab, to EG and PPY. This does not alter the authors' adherence to all of the PLOS ONE policies on sharing data and materials. Dr. HN has declared that no competing interest exists for her contribution.","2013","09","Eric A Gehrie","EAG",3,FALSE,2,1,3,3,TRUE,TRUE,TRUE,1,"3",TRUE
